Polar Capital’s Autolus Therapeutics AUTL Stock Holding History

Polar Capital’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$1.53M	–	264
2018 Q3	$1.53M	Hold	50,000	–	–	0.01%	254
2018 Q2	$1.34M	Buy	+50,000	New	+$1.32M	0.01%	247

Other funds holding AUTL

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Polar Capital's AUTL Position: Q4 2018 in Review

Polar Capital sold out of Autolus Therapeutics (AUTL) in Q4 2018, closing a stake of 50,000 shares — an estimated $1.53M sold.

Polar Capital first reported a position in AUTL in Q2 2018 and held it in 2 quarters. The position peaked at $1.53M in Q3 2018. 38 funds tracked by Wall St. Rank hold AUTL as of Q4 2018.

Polar Capital reported no remaining Autolus Therapeutics position as of Q4 2018 after selling out during the quarter.
Polar Capital sold 50,000 Autolus Therapeutics shares in Q4 2018, an estimated $1.53M.
Polar Capital first reported a position in Autolus Therapeutics in Q2 2018 and held it in 2 quarters.
Polar Capital's Autolus Therapeutics position peaked at $1.53M in Q3 2018.
38 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2018.

Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.